“…Among viral factors, genetic variability has been analyzed in order to determine the possible association between viral genetic features and infection outcome; several genes have been targeted for evaluation including those encoding for gB, glycoprotein N, glycoprotein O, and the UL144 gene, among others [6,11,12,13,14]. The gB gene has been studied in different risk groups, including both solid organ and hemopoietic transplant patients [5,15,16,17,18,19,20,21,22,23,24,25,26,27], HIV-infected patients [4,6,15,16,28,29,30,31,32,33], infants with congenital infection [3] and healthy subjects [34]. So far, studies directed towards assessing the impact of genotype features on disease have yielded conflicting results.…”